Big Tech’s AI dream demands real money — but even more wishing and hoping

• SoftBank brings vision and volatility to big tech bets

  AI is Masayoshi Son’s most ambitious bet yet
  
  Financial Times - 3h
• 

  The CFPB Work Freeze Is Putting Big Tech Regulations ‘On Ice’

  The cease-work order at the Consumer Financial Protection Bureau won’t just affect lawsuits and enforcement actions. It will stall regulation that could govern tech companies like Apple and Google.
  
  Wired - 17h

• Snap’s increased AI spending may push profits even further out

  Guggenheim downgraded Snap’s stock, warning that increased AI investments could defer operating profits until 2027.
  
  MarketWatch - 16h
• 

  The Big Idea: how do our brains know what’s real?

  From seeing things to hearing voices, there’s a finer line between hallucination and reality than you might suppose. When did you last hallucinate? “The visionary tendency is much more common among ...
  
  The Guardian - 2d

• Brussels becoming more supportive of Big Tech, says Booking CEO

  Also in this newsletter: ruling party to lose outright majority in Kosovo elections
  
  Financial Times - 2d

• Tech megacaps plan to spend more than $300 billion in 2025 as AI race intensifies

  Meta, Amazon, Alphabet and Microsoft intend to invest as much as $320 billion this year into AI advancement technologies.
  
  CNBC - 4d
• 

  Big Tech Keeps Its A.I. Data Center Spending Boom Alive

  An apparent breakthrough in efficiency from the Chinese start-up did not make tech’s biggest companies question their extravagant spending on new data centers.
  
  The New York Times - 4d

• Anduril in talks to raise money at $28 billion valuation as defense-tech booms

  Anduril has signed a term sheet to raise up to $2.5 billion at a valuation of $28 billion, according to sources close to the company.
  
  CNBC - 4d

More from MarketWatch

• I’m a wife and mother. Can I secretly change my will and leave everything to my daughter instead of my husband?

  “Happy Valentine’s Day (almost).”
  
  MarketWatch - 21m

• Lyft has ‘no obvious answers’ for its growth woes, as its stock declines

  One issue for Lyft is a downturn in pricing trends, which numerous analysts keyed in on as they looked to make sense of the path forward.
  
  MarketWatch - 30m

• 10-year Treasury yield has biggest one-day jump of 2025 after hot inflation data

  U.S. government debt aggressively sold off on Wednesday, pushing the benchmark 10-year yield up for a fifth straight session, after the consumer-price index for January exceeded expectations and ...
  
  MarketWatch - 39m

• Falling inflation-adjusted yields have cheered investors. Why it may not last.

  The yield on 10-year Treasury inflation-protected securities probably won’t keep falling this year despite its recent retreat, according to Capital Economics.
  
  MarketWatch - 40m

• Three reasons Nvidia’s stock is still compelling, and why it could rise 30% in the next year

  A screen of the S&P 500 still has Nvidia standing out, despite this year’s DeepSeek disruption for the stock.
  
  MarketWatch - 45m

More in Business

• Here's the inflation breakdown for January 2025 — in one chart

  The consumer price index rose 3% on the year in January 2025. Economists worry that broad disinflation is over, even as tariffs loom.
  
  CNBC - 6m

• Bank of America CEO on inflation impact on U.S. economy: ‘Rates are going to stay where they are’

  The Bureau of Labor Statistics reported hotter-than-expected growth in the U.S. consumer price index, forcing markets to recalibrate rate expectations.
  
  CNBC - 10m

• Lyft shares sink 7% on underwhelming fourth-quarter results

  Lyft shares shed about 7% after the ride-sharing app reported lackluster fourth-quarter results and weak bookings guidance due to rising competition.
  
  CNBC - 15m

• Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short

  Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
  
  CNBC - 15m

• Prebiotic soda brand Olipop valued at $1.85 billion in latest funding round

  Olipop's annual sales surpassed $400 million in 2024, as competition heats up with rivals like Poppi.
  
  CNBC - 17m